Change of individual vascular endothelial calcium during hyperthermia

Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy

In most drug delivery systems the clinician does not have control over the location of drug delivery after the therapeutic has been administered. As the location of the tumor mass is often known in many patients, a therapy system which enables the clinician to play an active role in nanomedicine localization would provide an advantage. Here, we show a new approach wherein a laser can be used to tag tumor tissue and enhance the delivery of targeted polymer therapeutics. Plasmonic gold nanorods are delivered to the cancerous tissue and heated by a laser to promote a targetable, hyperthermic response. Concurrent administration of a heat shock targeted polymer therapeutic thereby enhances site specific delivery.

Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery

Plasmonic photothermal therapy (PPTT) with gold nanostructures has been used to generate significant heat within tumors to ablate vasculature. Here we report the use of gold nanorod (GNR) mediated PPTT to induce moderate hyperthermia as a tool to enhance the delivery of macromolecules. GNRs were injected intravenously in a mouse sarcoma (S-180) tumor model. After 24h Evans blue dye (EBD) was injected and the right tumor was radiated with a laser diode for 10 min. EBD content in the right and left tumors were extracted in formamide, measured spectrophotometrically and expressed as a thermal enhancement ratio (TER). Enhanced delivery of EBD was observed (up to 1.8-fold) when tumor temperatures reached 43°C or 46°C. No statistical difference was observed between tumors at these two temperatures, though significant hemorrhage was observed in tumors and surrounding areas receiving the higher thermal dose (46°C). These results indicate that tumor directed PPTT may be used to induce moderate hyperthermia and therefore selectively increase the delivery of macromolecules with therapeutic anticancer drugs.

Study of heat shock response of human umbilical vein endothelial cells (HUVECs) using cDNA microarray

Genetic response of human umbilical vein cells (HUVECs) to heat shock was studied using gene expression analysis. HUVECs were subjected to heat treatment at 44 degrees C and 55 degrees C for 1 h, respectively. Four hours after the treatment, gene expression of the treated cells and control cells (37 degrees C) were profiled using cDNA microarray. Data were analyzed using bioinformatics tools, and the results were verified by real-time quantitative PCR experiment. It has been shown that a large number of genes were regulated indicating global response to heat treatment at the genetic level.

Heat shock induced apoptosis in normal and tumor human umbilical vein cells (HUVECs)

Human endothelial cell injury may play an important role tumor damage hyperthermia in vivo. In this study, human umbilical vein cells were heat shocked in vitro at different temperatures (41-55 degrees C). Cells were observed 0, 12, 24, 36, 48, 60 and 72 hours after heat shock. By incrementally increasing the heat load from 41-55 degrees C, we observed a gradually increase in apoptosis with a significant change from apoptotic to necrotic death at temperature beyond 45 degrees C. Further, an in vitro human breast tumor endothelial cell model was established to compare the heat shock response between normal and tumor endothelial cells.